Retroperitoneal fibrosis due to ergotamine. Apropos a case
Moltó Ripoll, F.; Merenciano Cortina, F.J.; Herraiz Romero, I.; Vilas Ferrol, I.; Fernández-Moscoso López-Duran, A.; Muñoz Nuñez, C.; Martínez Salinas, P.
Archivos Espanoles de Urologia 48(4): 400-403
1995
ISSN/ISBN: 0004-0614 PMID: 7598553 Document Number: 444465
This paper reviews retroperitoneal fibrosis secondary to ergotamine and evaluated the current tools in its diagnosis. A well documented case of a young patient with retroperitoneal fibrosis resulting from chronic use of ergotic agents is presented. The fibrous plaque remitted after withdrawal of the causal agent. The importance of contrast-enhanced CT in the diagnosis of retroperitoneal fibrosis is widely accepted. The usefulness of this technique in determining the extent of the lesion and for subsequent follow up is underscored.